Presentation is loading. Please wait.

Presentation is loading. Please wait.

USAGE OF DRUGS IN EUROPE LSD CANNABIS. ALL ADULTS (15-64) USAGE OF LSD IN EUROPE All adults (15-64) Usage of LSD in Europe datesample sizemalefemaletotal.

Similar presentations


Presentation on theme: "USAGE OF DRUGS IN EUROPE LSD CANNABIS. ALL ADULTS (15-64) USAGE OF LSD IN EUROPE All adults (15-64) Usage of LSD in Europe datesample sizemalefemaletotal."— Presentation transcript:

1 USAGE OF DRUGS IN EUROPE LSD CANNABIS

2 ALL ADULTS (15-64) USAGE OF LSD IN EUROPE All adults (15-64) Usage of LSD in Europe datesample sizemalefemaletotal Denmark2013104702.40%7.00%1.4% France2010227742.6%0.81%1.68% Germany201290843.0%1.30%2.20% Ireland2011606.7%2.20%4.40% Italy *2012188981.2%0.30%0.70% Norway20121668 Portugal201253550.9%0.30%0.60% Spain201122128 Sweden20126910 United Kingdom *2012215017.2%2.90%5.10%

3 ALL ADULTS (15-64) USAGE OF LSD IN EUROPE MALE & FEMALE TOTAL AVERAGES

4 COUNTRIES WERE ASKED TO REPORT RESULTS USING, AS FAR AS POSSIBLE, EMCDDA STANDARD AGE GROUPS (ALL ADULTS: 15-64, YOUNG ADULTS: 15-34). IN COUNTRIES WHERE AGE RANGES ARE MORE RESTRICTIVE, PREVALENCE ESTIMATES MAY TEND TO BE SLIGHTLY HIGHER 'SAMPLE SIZE' REFERS TO THE NUMBER OF ACTUAL RESPONDENTS TO THE SURVEY (NET SAMPLE). IN SOME CASES, NATIONAL SURVEYS COVER ORIGINALLY A BROADER AGE RANGE ('ORIGINAL AGE RANGE') THAN THAT PRESENTED HERE FOR THE STANDARD GROUPS 'ALL ADULTS'(15-64) AND 'YOUNG ADULTS' (15-34). THIS TABLE PRESENTS THE RESULTS FOR THE LAST SURVEYS AVAILABLE IN EACH COUNTRY. IT AIMS TO PRESENT AN OVERVIEW OF NATIONAL SURVEYS. SOME CITY SURVEYS REPORTED BY COUNTRIES WERE NOT INCLUDED AS THEY TEND TO PRODUCE HIGHER PREVALENCE ESTIMATES WHICH ARE NOT COMPARABLE WITH ESTIMATES FOR WHOLE COUNTRIES (OR LARGE REGIONS WITH BOTH URBAN AND RURAL AREAS). ITALY: THE MOST RECENT GENERAL POPULATION SURVEY REPORTED BY ITALY DISPLAY A WIDE VARIATION IN RESULTS COMPARED WITH THE PREVIOUS SURVEYS WHICH MAY REFLECT METHODOLOGICAL DIFFERENCES. THE DATA IS PROVIDED FOR INFORMATION, BUT GIVEN THE LACK OF COMPARABILITY BETWEEN SURVEYS SHOULD BE TREATED WITH CAUTION.

5 YOUNG ADULTS (15-34) USAGE OF LSD IN EUROPE datesample sizemalefemalestotal Austria200825582.50%1.10%1.90% Estonia2008545 Germany201237354.50%1.50%3.00% Greece200426200.60%0.20%0.40% Italy *201249661.60%0.50%1.00% Latvia201122581.90%0.60%1.30% Poland201214491.80%0.30%1.00% Romania201031080.20%0.10% Sweden20121998 Turkey20114039

6 ALL ADULTS (15-34) USAGE OF LSD IN EUROPEEUROPE MALE & FEMALE TOTAL AVERAGES

7 COUNTRIES WERE ASKED TO REPORT RESULTS USING, AS FAR AS POSSIBLE, EMCDDA STANDARD AGE GROUPS (ALL ADULTS: 15-64, YOUNG ADULTS: 15-34). IN COUNTRIES WHERE AGE RANGES ARE MORE RESTRICTIVE, PREVALENCE ESTIMATES MAY TEND TO BE SLIGHTLY HIGHER. SOME COUNTRIES HAVE RECALCULATED THEIR PREVALENCE FIGURES USING THE EMCDDA STANDARD AGE GROUPS. 'SAMPLE SIZE' REFERS TO THE NUMBER OF ACTUAL RESPONDENTS TO THE SURVEY (NET SAMPLE). IN SOME CASES, NATIONAL SURVEYS COVER ORIGINALLY A BROADER AGE RANGE ('ORIGINAL AGE RANGE') THAN THAT PRESENTED HERE FOR THE STANDARD GROUPS 'ALL ADULTS'(15-64) AND 'YOUNG ADULTS' (15-34).

8 ALL ADULTS (15-64) USING CANNABIS IN EUROPE YearSample sizemalesfemalestotal Austria2008376117.50%11.00%14.20% Belgium2008679218.00%10.80%14.30% Bulgaria2012532510.70%4.200%7.50% Croatia2012475620.90%10.40%15.60% Denmark20131047042.80%29.70%35.60% Finland2010187322.10%14.50%18.30% France20102277439.52%24.95%32.12% Germany2012908427.60%18.60%23.10%

9 ALL ADULTS (15-64) USING CANNABIS IN EUROPE MALE & FEMALE TOTAL AVERAGES

10 COUNTRIES WERE ASKED TO REPORT RESULTS USING, AS FAR AS POSSIBLE, EMCDDA STANDARD AGE GROUPS (ALL ADULTS: 15-64, YOUNG ADULTS: 15-34). IN COUNTRIES WHERE AGE RANGES ARE MORE RESTRICTIVE, PREVALENCE ESTIMATES MAY TEND TO BE SLIGHTLY HIGHER. SOME COUNTRIES HAVE RECALCULATED THEIR PREVALENCE FIGURES USING THE EMCDDA STANDARD AGE GROUPS. 'SAMPLE SIZE' REFERS TO THE NUMBER OF ACTUAL RESPONDENTS TO THE SURVEY (NET SAMPLE). IN SOME CASES, NATIONAL SURVEYS COVER ORIGINALLY A BROADER AGE RANGE ('ORIGINAL AGE RANGE') THAN THAT PRESENTED HERE FOR THE STANDARD GROUPS 'ALL ADULTS'(15-64) AND 'YOUNG ADULTS' (15-34). THIS TABLE PRESENTS THE RESULTS FOR THE LAST SURVEYS AVAILABLE IN EACH COUNTRY. IT AIMS TO PRESENT AN OVERVIEW OF NATIONAL SURVEYS. SOME CITY SURVEYS REPORTED BY COUNTRIES WERE NOT INCLUDED AS THEY TEND TO PRODUCE HIGHER PREVALENCE ESTIMATES WHICH ARE NOT COMPARABLE WITH ESTIMATES FOR WHOLE COUNTRIES (OR LARGE REGIONS WITH BOTH URBAN AND RURAL AREAS).

11 ALL YOUNG ADULTS (15-34) USING CANNABIS IN EUROPE yearSample sizemalesfemalestotal Austria2008255822.80%15.70%19.20% Belgium2008255032.90%19.50%26.00% Bulgaria2012207720.80%10.00%15.60% Croatia2012199532.00%18.40%25.30% Denmark2013319152.60%40.50%45.90% Finland201087532.70%25.10%29.00% France2010772753.31%36.97%45.10% Germany2012373540.00%30.40%35.30%

12 ALL YOUNG ADULTS (15-64) USING CANNABIS IN EUROPE MALE & FEMALE TOTAL AVERAGES

13 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 'Sample size' refers to the number of actual respondents to the survey (Net sample). In some cases, national surveys cover originally a broader age range ('original age range') than that presented here for the standard groups 'All adults'(15-64) and 'Young adults' (15-34). This table presents the results for the last surveys available in each country. It aims to present an overview of national surveys. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). France: The most recent general population survey reported by Italy display a wide variation in results compared with the previous surveys which may reflect methodological differences. The data is provided for information, but given the lack of comparability between surveys should be treated with caution Germany: The most recent general population survey reported by the Netherlands display a wide variation in results compared with 2005 which may reflect methodological differences. The data is provided for information, but given the lack of comparability between surveys should be treated with caution


Download ppt "USAGE OF DRUGS IN EUROPE LSD CANNABIS. ALL ADULTS (15-64) USAGE OF LSD IN EUROPE All adults (15-64) Usage of LSD in Europe datesample sizemalefemaletotal."

Similar presentations


Ads by Google